Does colchicine reduce mortality in patients with COVID-19 clinical syndrome? An umbrella review of published meta-analyses

BACKGROUND: Despite significant improvements in both treatment and prevention strategies, as well as multiple commissioned reviews, there remains uncertainty regarding the survival benefit of repurposed drugs such as colchicine in patients with Coronavirus Disease 2019 (COVID-19) clinical syndrome....

Descripción completa

Detalles Bibliográficos
Autores principales: Danjuma, Mohammed I., Sayed, Rana, Aboughalia, Maryam, Hassona, Aseel, Elsayed, Basant Selim, Elshafei, Mohamed, Elzouki, Abdelnaser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520783/
https://www.ncbi.nlm.nih.gov/pubmed/37767472
http://dx.doi.org/10.1016/j.heliyon.2023.e20155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520783/
https://www.ncbi.nlm.nih.gov/pubmed/37767472
http://dx.doi.org/10.1016/j.heliyon.2023.e20155

Ejemplares similares